Related Experiment Videos

[Renovascular hypertension. Changes and prognosis of the surgical treatment]

H Soejima1, K Ikegami, J Machida

  • 1Department of Urology, Kumamoto University Medical School.

Insights

Percutaneous transluminal angioplasty (PTA) is now the preferred treatment for renovascular hypertension. Surgical interventions are reserved for complex cases where PTA is ineffective, offering varying long-term blood pressure control.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Surgery
  • Nephrology

Context:

  • Retrospective analysis of 663 patients with renovascular hypertension treated surgically in Japan (1963-1988).
  • Investigated causes including fibromuscular dysplasia (FMD), atherosclerosis (SC), and aortitis syndrome (AO).
  • Surgical procedures included nephrectomy, aortorenal bypass, and autotransplantation.

Purpose:

  • To evaluate the long-term outcomes of surgical treatment for renovascular hypertension.
  • To compare the efficacy of different surgical approaches based on the underlying cause.
  • To assess the evolving role of surgery in the context of emerging endovascular techniques like PTA.

Summary:

  • Fibromuscular dysplasia (FMD) patients were younger (mean 27 years) compared to atherosclerosis (SC) (52 years) and aortitis syndrome (AO) (29 years).
  • Surgical success rates (normal blood pressure) varied: 77% for FMD, 59% for SC, and 50% for AO at 10 years.
  • PTA has reduced surgical case numbers, particularly for FMD, shifting surgical focus to complex and refractory cases.

Impact:

  • Highlights the shift towards PTA as the primary treatment for renovascular hypertension.
  • Demonstrates the continued, albeit diminished, role of surgery for complex vascular lesions.
  • Provides long-term prognosis data for surgical management of different renovascular hypertension etiologies.

Related Concept Videos